SPP1 and neoplasm: Compared with its precursor inflammatory monocyte TAM3_VCAN, TAM1_SPP1 enriched in metastatic lymph nodes has lower antigen‐presenting ability, but potentially remodels the immune microenvironment by suppressing T cell activation, possibly favoring early tumor cell lymph node colonization.